Use of human recombinant erythropoietin and prednisone for treatment of myelodysplastic syndrome with erythroid predominance in a dog

Journal of the American Veterinary Medical Association

Volumn 213, Issue 7, 1998, Pages 999-1001

  Boone, Laura I ^a   Knauer, Kenneth W ^a   Rapp, Steve W ^b   Stewart, Jerry F ^b   Modiano, Jaime F ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Northside Animal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DOG; DOG DISEASE; DRUG COMBINATION; ERYTHROID PRECURSOR CELL; FOLLOW UP; HEMATOCRIT; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PATHOLOGY; ANIMAL TISSUE; BONE MARROW BIOPSY; CLINICAL FEATURE; ERYTHROID CELL; HEMOLYTIC ANEMIA; HISTOPATHOLOGY; MICROPHOTOGRAPHY; NONHUMAN; ORAL DRUG ADMINISTRATION; REFRACTORY ANEMIA;

ANIMALS; BLOOD TRANSFUSION; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN, RECOMBINANT; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEMATOCRIT; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; PREDNISONE;

EID: 0032184940     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kouides PA, Bennett JM. Morphology and classification of myelodysplastic syndromes. Hematol Oncol Clin North Am 1992;6:485-499.
2. Jain NC, Blue JT, Grindem CB, et al. Proposed criteria for classification of acute myeloid leukemia in dogs and cats. Vet Clin Pathol 1991;20:63-82.
3. Jackson ML, Kruth SA. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985;26:245-250.
4. Weiss DJ, Raskin R, Zerbe C. Myelodysplastic syndrome in two dogs. J Am Vet Med Assoc 1985;187:1038-1040.
5. Jain NC. Classification of myeloproliferative disorders in cats using criteria proposed by the animal leukemia study group: a retrospective study of 181 cases (1969-1992). Comp Hematol Int 1993;3:125-134.
6. Durando MM, Alleman AR, Harvey JW. Myelodysplastic syndrome in a Quarter Horse gelding. Equine Vet J 1994;26:83-85.
7. Mittelman M, Lessin LS. Clinical applications of recombinant erythropoietin in myelodysplasia. Hematol Oncol Clin North Am 1994;8:993-1009.
8. Yoshida Y, Anzai N, Kawabata H, et al. Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment. Ann Hematol 1993;66:175-180.
9. Hellstrom E, Birgegard G, Lockner D, et al. Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol 1991;47:355-360.
10. Goy A, Belanger C, Casadevall N, et al. High doses of intravenous recombinant erythropoietin for the treatment of anemia in myelodysplastic syndromes. Br J Hematol 1993;84:232-237.
11. Stein RS. Clinical use of growth factors in the myelodysplastic syndromes. Am J Med Sci 1994;307:360-367.
12. Miyazaki E, Kohgo Y, Hirayama M, et al. Remission after erythropoietin administration for erythroleukemia - a case study. Blood 1993;82:1378-1380.
13. Ogilvie GK. Hematopoietic growth factors: frontiers for cure. Vet Clin North Am Small Anim Pract 1995;25:1441-1457.
14. Giger U. Erythropoietin and its clinical use. Compend Contin Educ Pract Vet 1992;14:25-34.
15. Jain NC. Immunohematology. In: Jain NC, ed. Essentials of veterinary hematology. Philadelphia: Lea & Febiger, 1993;381-406.
16. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993;45(Suppl 1):S3-S7.
17. Cohn LA. The influence of corticosteroids on host defense mechanisms. J Vet Intern Med 1991;5:95-104.
18. Cowgill LD, James KM, Levy JK, et al. Use of recombinant erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc 1998;212:521-528.